ArticleIrish journal of medical science2025
MiR-432-5p was involved in gestational diabetes mellitus by targeting COL5A2 regulation.
Article in Irish journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prevalence of gestational diabetes mellitus (GDM) has increased recently. Currently, there is no effective treatment method, so this study aims to find a new biomarker for GDM.
methodsMiR-432-5p expression and diagnostic value were detected in GDM by RT-qPCR and the receiver operating characteristic (ROC) curve. The correlation was analyzed utilizing Pearson correlation analysis. Logistic regression was utilized to analyze risk factors for GDM. To construct the GDM mouse model, female mice were fed a 45% kcal high-fat sucrose diet six weeks before mating to induce diabetes. MiR-432-5p was overexpressed and inhibited by injecting miR-432-5p agomir and miR-432-5p antagomir into the mice, and collagen type V alpha 2 chain (COL5A2) was overexpressed by injecting COL5A2 overexpression vectors into the mice.
resultsIn GDM, miR-432-5p decreased and had high diagnostic value, and miR-432-5p was a risk factor. In GDM, miR-432-5p was negatively correlated with fasting plasma glucose, 1 h plasma glucose, and 2 h plasma glucose. In the GDM mouse model, overexpressed miR-432-5p reduced the fasting plasma glucose and body weight, while inhibited miR-432-5p increased them. Overexpressed miR-432-5p decreased the proliferation and increased the apoptosis in the GDM mouse model, while inhibited miR-432-5p increased the proliferation and decreased the apoptosis. COL5A2 was negatively regulated by miR-432-5p in GDM. Overexpressed COL5A2 increased the proliferation and reduced the apoptosis in the GDM mouse model.
conclusionIn GDM, miR-432-5p decreased and might be a biomarker. COL5A2 was decreased and negatively correlated with miR-432-5p in GDM. MiR-432-5p and COL5A2 acted together on GDM.
Indexed as
Identifiers
40794255What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.